tiprankstipranks
Trending News
More News >
Natural Health Trends (NHTC)
NASDAQ:NHTC
Advertisement

Natural Health Trends (NHTC) AI Stock Analysis

Compare
256 Followers

Top Page

NHTC

Natural Health Trends

(NASDAQ:NHTC)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 4o)
Rating:48Neutral
Price Target:
$2.50
▼(-27.33% Downside)
Natural Health Trends' overall stock score is primarily impacted by its weak financial performance, characterized by declining revenue and profitability. The technical analysis indicates a bearish trend, further weighing on the score. While the high dividend yield and strategic initiatives provide some support, the negative P/E ratio and operating losses remain significant concerns.

Natural Health Trends (NHTC) vs. SPDR S&P 500 ETF (SPY)

Natural Health Trends Business Overview & Revenue Model

Company DescriptionNatural Health Trends Corp (NHTC) is a global direct-selling company that specializes in the development and marketing of premium wellness and personal care products. The company operates primarily in the health and wellness sector, offering a range of products that include dietary supplements, skincare, and other personal care items. NHTC's product lines are designed to promote overall health and well-being, positioning the company as a key player in the growing health-conscious consumer market.
How the Company Makes MoneyNHTC generates revenue primarily through direct sales of its products to consumers, leveraging a multi-level marketing (MLM) model that allows independent distributors to earn commissions on their sales and the sales made by their recruits. This creates a tiered income structure that incentivizes distributors to grow their networks. Key revenue streams include wholesale product sales to distributors, retail sales through the company's e-commerce platform, and potential international market expansion. Additionally, NHTC may engage in strategic partnerships and collaborations to enhance its product offerings and market presence, contributing to its overall earnings.

Natural Health Trends Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Feb 11, 2026
Earnings Call Sentiment Neutral
The earnings call reflected a mix of challenges and strategic actions. While the company is experiencing a decline in sales and increased operating losses, it is also actively addressing these challenges through operational discipline and market expansion efforts. The announcement of a cash dividend demonstrates confidence in the company's financial health. Overall, the sentiment is balanced given the ongoing economic uncertainties and strategic initiatives.
Q2-2025 Updates
Positive Updates
Incentive Programs and Market Expansion
Despite challenges, Natural Health Trends Corp. celebrated achievements with incentive trips to the Maldives and Paris and launched a new market in Colombia, which was met with strong enthusiasm.
Strong Operational Discipline
The company exercised operational discipline by focusing on expense management, inventory control, and a supply chain transition to mitigate tariff uncertainties.
Dividend Announcement
On July 28, the Board of Directors declared a cash dividend of $0.20 per share, payable on August 22 to stockholders of record as of August 12.
Negative Updates
Decline in Net Sales
Net sales for the second quarter were $9.8 million, a 6% decrease compared to the second quarter of 2024, largely due to economic uncertainty and trade tensions.
Decreased Sales in Hong Kong
Sales in Hong Kong, which constituted 82% of total sales, declined 5% year-over-year due to heightened economic uncertainty.
Increased Operating Loss
The operating loss for the quarter was $333,000 compared to $238,000 in the second quarter last year.
Reduced Cash and Equivalents
Total cash, cash equivalents, and marketable securities were reduced to $34.2 million at June 30, down from $41.9 million at March 31, mainly due to a tax installment payment and quarterly dividend payment.
Company Guidance
In the second quarter of 2025, Natural Health Trends Corp. reported net sales of $9.8 million, marking a 6% decline from the $10.5 million recorded in the same period of 2024. The company faced challenges due to economic uncertainties and trade tensions, particularly impacting sales in Hong Kong, which constituted 82% of total sales and saw a 5% year-over-year decline. Despite the decrease in sales, the gross profit margin remained relatively stable at 73.9%. Commissions expense increased slightly to 40.9% of total sales, up from 40.1% the previous year, partly due to higher commissions earned by members. Selling, general, and administrative expenses decreased by $235,000 to $3.6 million. The quarter concluded with an operating loss of $333,000 and net income of $15,000, or breakeven per diluted share, compared to $173,000, or $0.02 per diluted share, in the second quarter of 2024. The company also reported a significant decrease in total cash, cash equivalents, and marketable securities to $34.2 million from $41.9 million at the end of March, mainly due to a $5.1 million tax installment payment related to the 2017 U.S. Tax Cuts and Jobs Act and a quarterly dividend payment. Additionally, on July 28, the Board declared a cash dividend of $0.20 per share, payable on August 22 to stockholders of record as of August 12.

Natural Health Trends Financial Statement Overview

Summary
Natural Health Trends faces challenges with declining revenue and profitability, as well as negative cash flows. Despite a strong gross profit margin and low leverage, the company's financial health is hindered by negative EBIT and EBITDA margins, and a low net profit margin.
Income Statement
45
Neutral
Natural Health Trends has experienced declining revenue over the past few years, with a negative revenue growth rate of -2.89% in the TTM period. The gross profit margin remains strong at approximately 73.97%, indicating efficient cost management. However, the company struggles with profitability, as evidenced by negative EBIT and EBITDA margins, and a low net profit margin of 0.83% in the TTM period.
Balance Sheet
60
Neutral
The company's balance sheet shows a low debt-to-equity ratio of 0.078, suggesting conservative leverage. Return on equity is modest at 1.09%, indicating limited profitability. The equity ratio is not explicitly calculated, but the company maintains a solid equity base relative to its assets.
Cash Flow
40
Negative
Cash flow analysis reveals challenges, with negative operating cash flow and free cash flow in the TTM period. The free cash flow to net income ratio is slightly above 1, indicating that free cash flow covers net income. However, the negative free cash flow growth rate of -9.25% highlights cash flow management issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue40.87M42.96M43.92M49.13M60.01M62.07M
Gross Profit30.19M31.79M32.75M36.47M44.99M45.08M
EBITDA-1.27M-1.17M-1.51M-66.00K1.87M1.08M
Net Income-118.00K572.00K568.00K313.00K1.08M843.00K
Balance Sheet
Total Assets42.25M55.36M69.09M82.82M98.36M105.94M
Cash, Cash Equivalents and Short-Term Investments32.01M43.94M56.18M69.67M83.84M92.37M
Total Debt2.17M2.64M3.46M4.12M3.17M3.94M
Total Liabilities16.10M22.49M27.49M32.67M38.87M38.24M
Stockholders Equity26.15M32.87M41.60M50.15M59.49M67.70M
Cash Flow
Free Cash Flow-5.03M-3.42M-4.32M-5.00M791.00K1.67M
Operating Cash Flow-4.95M-3.37M-4.28M-4.85M1.02M1.89M
Investing Cash Flow5.56M-30.07M-46.00K-143.00K-225.00K-211.00K
Financing Cash Flow-9.21M-9.21M-9.21M-9.14M-9.14M-9.14M

Natural Health Trends Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.44
Price Trends
50DMA
4.36
Negative
100DMA
4.38
Negative
200DMA
4.47
Negative
Market Momentum
MACD
-0.28
Positive
RSI
38.12
Neutral
STOCH
31.31
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NHTC, the sentiment is Negative. The current price of 3.44 is below the 20-day moving average (MA) of 4.18, below the 50-day MA of 4.36, and below the 200-day MA of 4.47, indicating a bearish trend. The MACD of -0.28 indicates Positive momentum. The RSI at 38.12 is Neutral, neither overbought nor oversold. The STOCH value of 31.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NHTC.

Natural Health Trends Risk Analysis

Natural Health Trends disclosed 39 risk factors in its most recent earnings report. Natural Health Trends reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Natural Health Trends Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
50
Neutral
$58.96M-9.30-60.59%63.86%
48
Neutral
$50.43M144.55-0.38%31.75%-5.07%-115.50%
42
Neutral
$33.24M-0.98-8.63%5.62%
40
Underperform
$21.91M-2.71-11.43%-12.53%-3.24%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NHTC
Natural Health Trends
3.44
-2.26
-39.65%
TBHC
Brand House Collective
1.41
-0.31
-18.02%
MOGU
Mogu
2.88
0.85
41.87%
MI
NFT
4.05
-4.49
-52.58%
OCG
Oriental Culture Holding
2.24
1.00
80.65%
JBDI
JBDI Holdings Limited
1.21
0.50
70.42%

Natural Health Trends Corporate Events

Natural Health Trends Corp. Reports Q3 2025 Results
Nov 6, 2025

Natural Health Trends Corp., a direct-selling and e-commerce company, markets premium personal care and wellness products under the NHT Global brand across Asia, the Americas, and Europe. In its third-quarter 2025 financial report, the company announced a 5% sequential increase in orders, despite a 5% year-over-year decline. The company is undergoing restructuring initiatives expected to save $1.5 million annually by mid-2026, and has declared a quarterly cash dividend of $0.20 per share.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 08, 2025